Charles River Laboratories ($CRL) has extended its partnership with CHDI Foundation, signing up for 5 more years of work spotlighting new treatments for Huntington's disease. The two have worked together since 2005 to discover novel drugs for the neurodegenerative disease, with Charles River providing a suite of preclinical services to CHDI's neuroscience experts. More